Pivot Bio - About the company
Pivot Bio is a series D company based in Berkeley (United States), founded in 2010 by and . It operates as a Provider of microbe-based crop nutrition products. Pivot Bio has raised $618M in funding from investors like DCVC, Temasek and Monsanto, with a current valuation of $2B. The company has 470 active competitors, including 112 funded and 33 that have exited. Its top competitors include companies like Amyris, Syngenta and AskBio.
Sectors and market segments that Pivot Bio operate in
Pivot Bio serves in the B2B space in the Life Sciences, Food and Agriculture Tech, Chemicals and Materials Tech market segments.The primary business model of Pivot Bio are:Company Details
Provider of microbe-based crop nutrition products. It develops and offers nitrogen-fixing microorganisms that develop a symbiotic relationship with corn plants, and fix atmospheric nitrogen directly into the roots through biological nitrogen fixation. It uses an in-furrow method of application and performs regardless of topography, weather, or soil type.
- Website
- Social
- Email ID
- @pivotbio.com
- Phone Number
- +1 , +1
Key Metrics
Founded Year
2010
Location
Berkeley, United States
Stage
Series D
Total Funding
in 7 rounds
Latest Funding Round
Post Money Valuation
as on Sep 16, 2021
Investors
Ranked
18th among 470 active competitors
Employee Count
as on Dec 31, 2022
Similar Companies
Amyris &
Legal entities associated with Pivot Bio
Pivot Bio is associated with 2 legal entities given below:
Legal Entity Name | Date of incorporation | Revenue | Net Profit | Employee Count |
|---|---|---|---|---|
Dec 13, 2022 | - | 506 | 779 | |
Dec 26, 999 | - | 789 | 777 |
Get your free copy of Pivot Bio's company profile
Pivot Bio's funding and investors
Pivot Bio has raised a total funding of $618M over 7 rounds. Its first funding round was on Oct 30, 2014. Its latest funding round was a Series D round on Jul 19, 2021 for $430M. 5 investors participated in its latest round, lead by DCVC and Temasek.
Pivot Bio has 26 institutional investors including DCVC, Temasek and Monsanto. Alan Cohen and 1 other are Angel Investors in Pivot Bio.
Here is the list of recent funding rounds of Pivot Bio:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
|---|---|---|---|---|---|
Jul 19, 2021 | $430M | Series D | $2B | - | |
May 11, 2020 | $100M | Series C | - | - | |
Oct 02, 2018 | $71.3M | Series B | - | - |
Access funding benchmarks and valuations. Sign up today!View details of Pivot Bio's funding rounds and investors
Pivot Bio's founders and board of directors
The founders of Pivot Bio are and . is the CEO of Pivot Bio.
View details of Pivot Bio's Founder profiles and Board Members
Pivot Bio's employee count trend
Pivot Bio has 256 employees as of Dec 22. The total employee count is 81.6% more than what it was in Dec 21. Here is Pivot Bio's employee count trend over the years:
Uncover Pivot Bio's growth story! Sign up today!Pivot Bio's Competitors and alternates
Top competitors of Pivot Bio include Amyris, Syngenta and AskBio. Here is the list of Top 10 competitors of Pivot Bio, ranked by ÃØÃÜÑо¿Ëù score :
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | ÃØÃÜÑо¿Ëù Score |
|---|---|---|---|---|---|
1st | Amyris 2003, Emeryville (United States), Public | Developer of renewable products for industrial solutions | $487M | Hercules Capital, TPGÌý&²¹³¾±è;Ìý | 80/100 |
2nd | Syngenta 2000, Basel (Switzerland), Acquired | Provider of crop inputs for farming | - | 78/100 | |
3rd |  AskBio 2001, Durham (United States), Acquired | Provider of gene and protein therapies to treat various diseases | $235M | TPG, Golden Valley CapitalÌý&²¹³¾±è;Ìý | 74/100 |
4th | Sherlock 2019, Watertown (United States), Acquired | Provider of a diagnostic platform for DNA and RNA detection | $111M | , Catalio Capital ManagementÌý&²¹³¾±è;Ìý | 73/100 |
5th | Ginkgo Bioworks 2008, Boston (United States), Public | Provider of gene editing-based cultured ingredients for agriculture industry | $796M | General Atlantic, T. Rowe PriceÌý&²¹³¾±è;Ìý | 71/100 |
6th | Antheia 2013, Palo Alto (United States), Series B | Genetically engineered yeast cells to produce medicinal products | $96.4M | SVB, Oxford FinanceÌý&²¹³¾±è;Ìý | 69/100 |
7th |  Twist Bioscience 2013, San Francisco (United States), Public | Developer of a semiconductor-based DNA synthesis platform | $321M | Foresite Capital, Bay City CapitalÌý&²¹³¾±è;Ìý | 69/100 |
8th |  Asimov 2017, Boston (United States), Series B | AI-based computer-aided designing tool for drug discovery | $209M | CPP Investments, DCVCÌý&²¹³¾±è;Ìý | 69/100 |
9th | Inovio Pharmaceuticals 1983, Plymouth Meeting (United States), Public | Developer of vaccines for the treatment of cancer and infectious diseases | - | , Ìý&²¹³¾±è;Ìý | 68/100 |
10th | Synthego 2012, Redwood City (United States), Series E | Developer of CRISPR-engineered cell and gene therapies | $460M | Wellington, Perceptive AdvisorsÌý&²¹³¾±è;Ìý | 68/100 |
18th |  2010, Berkeley (United States), Series D | Provider of microbe-based crop nutrition products | $618M | 58/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Pivot Bio's competitors? Click to see the top ones
Pivot Bio's Investments and acquisitions
Pivot Bio has made no investments or acquisitions yet.
Reports related to Pivot Bio
Here is the latest report on Pivot Bio's sector:
View
News related to Pivot Bio
Media has covered Pivot Bio for a total of 17 events in the last 1 year, 5 of them have been about company updates and 5 about partnerships.
•
PR Newswire•Mar 25, 2025•Pivot Bio
•
PR Newswire•Mar 14, 2025•Pivot Bio
•
PR Newswire•Mar 01, 2025•Pivot Bio
•
World Fertilizer•Feb 17, 2025•Pivot Bio
•
PR Newswire•Feb 12, 2025•Pivot Bio,
•
PR Newswire•Jan 24, 2025•Pivot Bio,
•
World Fertilizer•Jan 24, 2025•Pivot Bio,
•
The Business Journals•Jan 22, 2025•Pivot Bio
•
PR Newswire•Jan 16, 2025•Pivot Bio,
•
PR Newswire•Jan 09, 2025•Pivot Bio
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Frequently asked questions about Pivot Bio
When was Pivot Bio founded?
Pivot Bio was founded in 2010.Where is Pivot Bio located?
Pivot Bio is located in Berkeley, United States.Is Pivot Bio a funded company?
Pivot Bio is a funded company, its first funding round was on Oct 30, 2014.When was the latest funding round of Pivot Bio?
Pivot Bio's latest funding round was on Jul 19, 2021.How much is Pivot Bio worth?
The latest valuation of Pivot Bio is $2B as on Sep 16, 2021.What is the annual revenue of Pivot Bio?
Annual revenue of Pivot Bio is undefined as on undefined.Is Pivot Bio a Genomics company?
The primary sectors of Pivot Bio are Genomics, Crop Tech and Chemicals Tech.Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
4M+ Companies- 212K+ Investors
- 580K+ Funding Rounds
- 207K+ Acquisitions
- 2.9K+ Sectors
- 57K+ Business Models
Are you a Founder ?
Explore our recently published companies
- Nomad Coder AI - Taipei based, 2024 founded, Unfunded company
- Bhavye EV Products - Nalanda based, 2024 founded, Unfunded company
- HR180 - Amman based, 2012 founded, Funding Raised company
- Redlink - Salzburg based, 2013 founded, Funding Raised company
- Debovan Edu Evolve - Bengaluru based, 2024 founded, Unfunded company
- Ackuity - United States based, 2024 founded, Unfunded company
